UnitedHealth Group (NYSE:UNH) Trading Up 1.4%

Shares of UnitedHealth Group Incorporated (NYSE:UNH) were up 1.4% during mid-day trading on Thursday . The stock traded as high as $495.38 and last traded at $494.00. Approximately 1,176,298 shares were traded during trading, a decline of 74% from the average daily volume of 4,489,690 shares. The stock had previously closed at $487.30.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on UNH shares. Barclays lifted their price target on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Truist Financial reissued a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Oppenheimer reissued an “outperform” rating and set a $610.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Finally, Royal Bank of Canada decreased their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research report on Wednesday, April 17th. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Trading Up 0.3 %

The firm has a market capitalization of $455.76 billion, a price-to-earnings ratio of 30.28, a P/E/G ratio of 1.43 and a beta of 0.54. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The business has a 50-day moving average of $485.84 and a two-hundred day moving average of $514.21.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same period in the previous year, the business earned $6.26 EPS. UnitedHealth Group’s revenue was up 8.6% compared to the same quarter last year. Research analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

Hedge Funds Weigh In On UnitedHealth Group

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Secure Asset Management LLC boosted its stake in UnitedHealth Group by 0.8% in the 3rd quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock worth $1,238,000 after purchasing an additional 19 shares during the period. Iron Horse Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 1.6% during the 3rd quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock worth $614,000 after buying an additional 19 shares during the last quarter. Bensler LLC boosted its stake in shares of UnitedHealth Group by 0.3% during the 3rd quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock worth $3,677,000 after buying an additional 19 shares during the last quarter. Texas Capital Bancshares Inc TX boosted its stake in shares of UnitedHealth Group by 1.1% during the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock worth $855,000 after buying an additional 19 shares during the last quarter. Finally, Tealwood Asset Management Inc. boosted its stake in shares of UnitedHealth Group by 0.4% during the 4th quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock worth $2,626,000 after buying an additional 19 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.